Immuron continued quarterly sales growth Sales Highlights (unaudited): Global • Q1 sales AUD$2.2 million up 9% on prior comparative period (pcp) • Q1 sales up 5% on prior quarter Australia • Q1 sales AUD$1.8 million up 14% on prior comparative period (pcp) • Q1 sales up 12% on prior quarter...
Immuron FY27 Sales Update
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Immuron Limited has reported its sales growth for the first quarter of the fiscal year, highlighting a significant increase in sales across various regions, particularly in Australia and Canada. However, sales in the U.S. experienced a decline due to logistical challenges and inventory issues, although there is optimism for recovery in the upcoming quarter. Overall, the report indicates a positive trend in sales performance for Immuron, reflecting its ongoing growth strategy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Story so far
Earlier from Immuron
- CEO to present at Emerging Growth Conference
- Notice of Annual General Meeting and Proxy Form
- Travelan Phase 2 Study Results Published
- Change in substantial holding
- Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F)
Later from Immuron
- Immuron Updates At-The-Market Funding Facility
- Emerging Growth Conference Presentation
- Immuron Engages LifeSci Capital
- Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron